﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Life Sciences Updates from Cooley LLP</title><description>Life Sciences Updates from Cooley LLP</description><link>http://www.cooley.com</link><item><title>Cooley Advises Arena Pharmaceuticals in Marketing and Supply Agreement with Eisai Inc.</title><description>&lt;p&gt;&lt;em&gt;The Cooley team representing Arena Pharmaceuticals from Cooley's &lt;/em&gt;&lt;a href="http://www.cooley.com/corporatepartnering" target=_self&gt;&lt;em&gt;Life Sciences Corporate Partnering &amp;amp; Licensing&lt;/em&gt;&lt;/a&gt;&lt;em&gt; practice included partners &lt;/em&gt;&lt;a href="http://www.cooley.com/afreemangleason" target=_se...</description><link>http://www.cooley.com/showpressrelease.aspx?Show=64018</link><pubDate>Thu, 01 Jul 2010 00:00:00 GMT</pubDate></item><item><title>54 Attorneys and 22 Practice Areas Recognized in &lt;em&gt;Chambers USA&lt;/em&gt; 2010 Edition</title><description>&lt;p&gt;&lt;strong&gt;Palo Alto, Calif. – June 29, 2010&lt;/strong&gt; – Cooley LLP announced that the 2010 edition of &lt;em&gt;Chambers USA: America's Leading Lawyers for Business&lt;/em&gt; recognizes 54 Cooley attorneys as leaders in their respective fields, with 15 attorneys receiving a #1 ranking. Six Cooley practices rec...</description><link>http://www.cooley.com/showpressrelease.aspx?Show=63998</link><pubDate>Tue, 29 Jun 2010 00:00:00 GMT</pubDate></item><item><title>Survey of Biotech Executives Reveals Strong Interest in Tax Credit Program, Forecasts Hiring Plans</title><description>&lt;p&gt;&lt;strong&gt;Palo Alto, Calif. – June 18, 2010 –&lt;/strong&gt; Cooley LLP today announced results of a survey conducted to gauge interest among biotech executives in the Qualifying Therapeutic Discovery tax credit and grant provisions of the Health Care Reform Act, as well as potential job creation resulti...</description><link>http://www.cooley.com/showpressrelease.aspx?Show=63977</link><pubDate>Fri, 18 Jun 2010 00:00:00 GMT</pubDate></item><item><title>Treasury Announces Guidelines for Applying for §48D Tax Credits and Cash Grants for Life Sciences Companies</title><description>&lt;p&gt;&lt;strong&gt;Application Window is June 21, 2010–July&amp;nbsp;21, 2010&lt;/strong&gt;&lt;br&gt;    &lt;strong&gt;&lt;a href="http://op.bna.com/dt.nsf/id/csaz-85nj6r/$File/N-10-45.pdf"&gt;Treasury Department Notice&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;On May 21, 2010, the U.S. Department of the Treasury ("Treasury") released guidelines (the "Noti...</description><link>http://www.cooley.com/showalert.aspx?Show=63922</link><pubDate>Fri, 21 May 2010 00:00:00 GMT</pubDate></item><item><title>Update on Section 48(D) Tax Credit Program Activities</title><description>&lt;p&gt;This serves as a reminder that guidelines for the Qualifying Therapeutic Discovery tax credit and grant provisions of the Health Care Reform Act (also called the Section 48(D) program) are scheduled for release this Friday, May 21.  We encourage companies with potentially qualified programs to be...</description><link>http://www.cooley.com/showalert.aspx?Show=63901</link><pubDate>Mon, 17 May 2010 00:00:00 GMT</pubDate></item><item><title>Life Sciences Companies Should Begin Now to Prepare to Apply for Federal Cash Grants and Tax Credits</title><description>&lt;p&gt;There are a number of steps a life sciences company can take to be ready to apply for cash grants or tax credits under the $1&amp;nbsp;billion program authorized by the new healthcare reform law.&lt;sup&gt;1&lt;/sup&gt; Early preparation is key as the program is expected to have tight submission deadlines and be...</description><link>http://www.cooley.com/showalert.aspx?Show=63843</link><pubDate>Fri, 30 Apr 2010 00:00:00 GMT</pubDate></item><item><title>Healthcare Reform Law Will Provide Cash Grants and Tax Credits for Qualifying Life Sciences Companies</title><description>	&lt;p&gt;The recently enacted healthcare reform law created a new program that will provide cash grants and tax credits for certain emerging life sciences companies. The program applies to companies with no more than 250 employees performing qualified research and development during 2009 and 2010. &lt;/p&gt;	&lt;...</description><link>http://www.cooley.com/showalert.aspx?Show=63754</link><pubDate>Wed, 31 Mar 2010 00:00:00 GMT</pubDate></item><item><title>Cooley Advises Sequenom on Worldwide Licensing Agreement for Macular Degeneration Genetic Test</title><description>&lt;p&gt;&lt;em&gt;The Cooley team representing Sequenom included partner &lt;a href="http://www.cooley.com/kchandler" target=_self&gt;Kay Chandler&lt;/a&gt; and associate &lt;a href="http://www.cooley.com/ecarter" target=_self&gt;Elizabeth Carter&lt;/a&gt;. &lt;/em&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;SAN DIEGO, Feb 09, 2010 &lt;/strong&gt;/PRNewswire via COMTEX...</description><link>http://www.cooley.com/showpressrelease.aspx?Show=63639</link><pubDate>Tue, 09 Feb 2010 00:00:00 GMT</pubDate></item><item><title>Partner Comments on San Diego Biotech Industry</title><description>&lt;p&gt;Partner &lt;a href="http://www.cooley.com/wfishburn" target=_self&gt;Wain Fishburn&lt;/a&gt; commented on the changing relationship between biotech companies and big pharmaceutical companies. His remarks were made during a panel discussion sponsored by BIOCOM, a life sciences industry group in San Diego, and...</description><link>http://www.cooley.com/showinthenews.aspx?Show=63410</link><pubDate>Thu, 19 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Cooley Advises Alder Biopharmaceuticals in Global Agreement with Bristol-Myers Squibb</title><description>&lt;p&gt;&lt;em&gt;The Cooley team representing Alder Biopharmaceuticals included partners &lt;a href="bkosacz"&gt;Barbara Kosacz&lt;/a&gt;, &lt;a href="mpostner"&gt;Marya Postner&lt;/a&gt;, &lt;a href="serickson"&gt;Sonya Erickson&lt;/a&gt;, and special counsel &lt;a href="gempey"&gt;Gordon Empey&lt;/a&gt; and &lt;a href="dleith"&gt;Deb Leith&lt;/a&gt;.&amp;nbsp;&lt;/em&gt;&lt;/p&gt;...</description><link>http://www.cooley.com/showpressrelease.aspx?Show=63333</link><pubDate>Tue, 10 Nov 2009 00:00:00 GMT</pubDate></item></channel></rss>